Landscapes / Targets

CDK4/6

13 drugs act on CDK4/6, in 54 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs13

DrugHow it worksCompanyStageNext dateDetails
Kinase inhibitor
Pfizer · Public PFE
Approved 30 Dec 2026Phase 3 trial completes
Kinase inhibitor
Approved 1 Feb 2027Phase 2 trial completes
Kinase inhibitor
Eli Lilly · Public LLY
Approved Feb 2027Phase 2 trial completes
Cyclin-dependent kinase inhibitor
Approved 15 Jul 2027Phase 3 trial completes
Cyclin-dependent kinase inhibitor
Genor Biopharma · Public 6998.HK
Approved in China —
—
Phase 2/3 1 Dec 2026soonPhase 2/3 trial completes
Cyclin-dependent kinase inhibitor
Pfizer · Public PFE
Phase 3 2 Jan 2029Phase 3 trial completes
—
Phase 3 —
Cyclin-dependent kinase inhibitor
Phase 1/2 31 Dec 2026Phase 1/2 trial completes
Mocaciclibnot checked
Cyclin-dependent kinase inhibitor
Phase 1/2 31 Mar 2029Phase 1/2 trial completes
—
Tasly · Public 600535.SS
Phase 1 31 Dec 2026Phase 1 trial completes
—
Phase 1 30 Sep 2027Phase 1 trial completes
—
Phase 1 —

About this list

Checked
12 of 13 drugs. The other 1 is marked “not checked” in the list. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow CDK4/6

Following is part of Solo: you see every change to CDK4/6 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in